Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05%
Product Images NDC 72934-1050

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05% (NDC 72934-1050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D (2 End)

FDA Label Image

D (1050 2 Front)

D (1050 2 Front)
This is a prescription medication with the NDC code of 72934-1050-2. It contains Clindamycin Phosphate, an antibiotic that is commonly used to treat skin infections, along with Niacinamide and Azarotene, which are used to treat acne. The medication comes in a 30g tube.*
FDA Label Image

S (1050 2 Middle)

S (1050 2 Middle)
This is a medication with active ingredients Clindamycin Phosphate and Niacinamide, and an inactive ingredient Suspendisse Gel. The percentages of active ingredients are 1% and 0.05%, respectively. No further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.